Discover the crucial aspects of product development and manufacturing for biopharma and medtech businesses at this insightful networking event.

Join us for a panel discussion and networking breakfast at Australia's newest biotech incubator, Jumar Bioincubator. Gain industry insights and build connections in the biotech sector with a panel discussion led by Jumar's General Manager, Camille Shanahan that will cover:

How to harmonise manufacturing for human use right from the start
The clinical-grade prerequisites you navigate to get to market
Scaling up efficiently to adhering to Good Manufacturing Practices (GMP)
Guidance on how to secure those all-important regulatory approvals

Meet the panelists

Campbell Robertson-Smith, Chief Financial Officer of Incisive Technologies, an Australian medical device manufacturer bringing a dental diagnostic to market
Fiona Seddon, Consultant at Just Partnering, specialising in aligning early preclinical and clinical development plans with regulatory requirements, and product analytics.
Dr Jennifer Hollands, Government and Academic Liaison at Cell Therapies, responsible for collaborations with Australian agencies, medical research institutes and researchers.
Vanessa Sandford, Exec Director of Global Drug Product Development Plasma Product Development at CSL, responsible for the delivery of global development and product support for PPD related activities from drug substance to final container including primary packaging and medical devices

The panel and networking breakfast will be followed by tour of Jumar's facilities, and an opportunity to find out how you can get involved in this exciting journey as we pave the way for the next generation of biotech innovators.

This event is part of the Melbourne Connect Innovation Week: find out more

About

Set to open it's doors in late 2023, Jumar Bioincubator will act as a first home for biotech startups, providing affordable lab and office space, practical support, and community activities to unlock the potential in early scientific discoveries.

Jumar Bioincubator was established by CSL, WEHI and the University of Melbourne. Together, with backing from innovation investor Breakthrough Victoria and operator Cicada Innovations, the mission is to connect early-stage and scaling biotech ventures with the support they need to progress discoveries towards real-world treatments and therapies and build a critical mass of scientists with the knowledge and confidence to run successful biomedical ventures.